Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by ronrydellon Jul 30, 2015 10:06am

138 Views

Post# 23975477

We need some confidence and action!

I would be nice to get some new buying and in some quantity to get our favorite color of GREEN back. I'm getting so sick of seeing RED every day but I don't anything on the horizon until the September 30 meeting when we get our usual dose of "euphoria and how great the horizon is looking".

Getting an official FDA approval will change everything for the short term as we then go through another loooonnnngggg wait as the Phase III testing works its way to a conclusion to see if this drug will have some long term legs.

SOMEBODY start buying as I'm all tapped out on this play!

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta